PRS4 COST OF TREATMENT AND REIMBURSEMENT OF HOSPITALIZED COMMUNITY-ACQUIRED PNEUMONIA WITH I.V. MOXIFLOXACIN COMPARED TO STANDARD ANTIBIOTIC TREAMENT IN GERMANY
نویسندگان
چکیده
منابع مشابه
Treatment of hospitalized patients with community-acquired pneumonia.
Effective empiric treatment of pneumonia requires antibiotic coverage against gram-negative and gram-positive pathogens, including drug-resistant isolates. We compared the safety and efficacy of intravenous (i.v.) cefepime (2 g administered every 12 h) to those of i.v. ceftriaxone (1 g administered every 12 h) for the empiric treatment of hospitalized patients with community-acquired pneumonia....
متن کاملAn intervention to improve antibiotic delivery and sputum procurement in patients hospitalized with community-acquired pneumonia.
STUDY OBJECTIVES To determine if an educational intervention targeting emergency department (ED) and medicine staff could successfully decrease the time to antibiotic delivery (door-to-drug delivery time [DDD]) for patients admitted through the ED with community-acquired pneumonia (CAP). DESIGN Prospective, multidisciplinary team-based educational project. Demographics, outcomes, and processe...
متن کاملDuration of Antibiotic Treatment in Community-Acquired Pneumonia.
The optimal duration of antibiotic treatment in communityacquired pneumonia (CAP) has not been completely established, and there are discrepancies even between various clinical guidelines published to date. The British Thoracic Society1 recommends 7 days of antibiotic treatment in patients with uncomplicated mild to moderate CAP. In 2011, the ERS2 published guidelines recommending that treatmen...
متن کاملEffectiveness of oral moxifloxacin in standard first-line therapy in community-acquired pneumonia.
Based on recent guidelines for the management of community-acquired pneumonia, this study was designed to evaluate the effectiveness of a new fluoroquinolone compared with standard antimicrobial regimens, in conditions relating as closely as possible to the real world setting. In this study, 564 patients were randomised to either oral moxifloxacin (400 mg o.d.) or to standard oral therapy (amox...
متن کاملA brief review of moxifloxacin in the treatment of elderly patients with community-acquired pneumonia (CAP)
Community-acquired pneumonia (CAP) remains a common cause of morbidity and a potentially life-threatening illness throughout the world mainly in elderly patients. Initial antibacterial treatment, usually empirical, should be as effective as possible in order to assure rapid clinical resolution and reduce high rates of hospitalization and mortality especially affecting aged patients. New fluoroq...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Value in Health
سال: 2004
ISSN: 1098-3015
DOI: 10.1016/s1098-3015(10)65928-1